Literature DB >> 16304091

Prostate cancer: local staging at 3-T endorectal MR imaging--early experience.

Jurgen J Fütterer1, Stijn W T P J Heijmink, Tom W J Scheenen, Gerrit J Jager, Christina A Hulsbergen-Van de Kaa, J Alfred Witjes, Jelle O Barentsz.   

Abstract

PURPOSE: To prospectively investigate the local staging accuracy of 3-T endorectal magnetic resonance (MR) imaging for prostate cancer by using whole-mount-section histopathologic analysis as the standard of reference.
MATERIALS AND METHODS: This study was approved by the institutional review board, and informed consent was obtained from all patients. In 35 consecutive patients (median age, 62.3 years) with biopsy-proved prostate cancer, 3-T endorectal MR imaging was performed. High-spatial-resolution endorectal T2-weighted fast spin-echo images of the prostate were obtained in three planes. MR images were prospectively evaluated by two experienced radiologists and a third radiologist who was less experienced with regard to local disease extent by using five established extracapsular criteria. Whole-mount-section histopathologic analysis was the standard of reference. Evaluation was performed according to octant and patient. Sensitivity, specificity, positive and negative predictive values, overall accuracy, and interobserver agreement were calculated.
RESULTS: Thirty-two patients who underwent radical prostatectomy were enrolled in this study. Accuracy, sensitivity, and specificity of local staging were 94% (30 of 32), 88% (seven of eight), and 96% (23 of 24), respectively, for both experienced radiologists, and these values were 81% (26 of 32), 50% (four of eight), and 92% (22 of 24), respectively, for the less experienced radiologist. There was substantial agreement between both experienced readers (kappa = 0.42-0.79) and moderate agreement between the less experienced reader and the experienced readers with respect to all extracapsular criteria. In regard to the three cases of minimal capsular invasion, two were detected by both experienced radiologists.
CONCLUSION: In this study, high accuracy for staging of prostate cancer at 3-T endorectal MR imaging, with moderate to substantial observer agreement, was demonstrated. In addition, minimal capsular invasion could be detected. RSNA, 2005.

Entities:  

Mesh:

Year:  2005        PMID: 16304091     DOI: 10.1148/radiol.2381041832

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  40 in total

1.  Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.

Authors:  B Nicolas Bloch; Elizabeth M Genega; Daniel N Costa; Ivan Pedrosa; Martin P Smith; Herbert Y Kressel; Long Ngo; Martin G Sanda; William C Dewolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2012-06-03       Impact factor: 5.315

2.  [MR techniques for noninvasive diagnosis of prostate cancer].

Authors:  N Morakkabati-Spitz; P J Bastian; A Meissner; F Träber; J Gieseke; H H Schild; S C Müller
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

3.  Magnetic resonance imaging and spectroscopy of prostate cancer.

Authors:  Peter R Carroll; Fergus V Coakley; John Kurhanewicz
Journal:  Rev Urol       Date:  2006

4.  A data-driven approach to prostate cancer detection from dynamic contrast enhanced MRI.

Authors:  Nandinee Fariah Haq; Piotr Kozlowski; Edward C Jones; Silvia D Chang; S Larry Goldenberg; Mehdi Moradi
Journal:  Comput Med Imaging Graph       Date:  2014-07-05       Impact factor: 4.790

5.  UMMPerfusion: an open source software tool towards quantitative MRI perfusion analysis in clinical routine.

Authors:  Frank G Zöllner; Gerald Weisser; Marcel Reich; Sven Kaiser; Stefan O Schoenberg; Steven P Sourbron; Lothar R Schad
Journal:  J Digit Imaging       Date:  2013-04       Impact factor: 4.056

6.  Multiparametric MRI maps for detection and grading of dominant prostate tumors.

Authors:  Mehdi Moradi; Septimiu E Salcudean; Silvia D Chang; Edward C Jones; Nicholas Buchan; Rowan G Casey; S Larry Goldenberg; Piotr Kozlowski
Journal:  J Magn Reson Imaging       Date:  2012-01-20       Impact factor: 4.813

7.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.

Authors:  Baris Turkbey; Haresh Mani; Vijay Shah; Ardeshir R Rastinehad; Marcelino Bernardo; Thomas Pohida; Yuxi Pang; Dagane Daar; Compton Benjamin; Yolanda L McKinney; Hari Trivedi; Celene Chua; Gennady Bratslavsky; Joanna H Shih; W Marston Linehan; Maria J Merino; Peter L Choyke; Peter A Pinto
Journal:  J Urol       Date:  2011-09-25       Impact factor: 7.450

Review 8.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

9.  The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Authors:  Berrend G Muller; Jurgen J Fütterer; Rajan T Gupta; Aaron Katz; Alexander Kirkham; John Kurhanewicz; Judd W Moul; Peter A Pinto; Ardeshir R Rastinehad; Cary Robertson; Jean de la Rosette; Rafael Sanchez-Salas; J Stephen Jones; Osamu Ukimura; Sadhna Verma; Hessel Wijkstra; Michael Marberger
Journal:  BJU Int       Date:  2013-11-13       Impact factor: 5.588

10.  Modalities for imaging of prostate cancer.

Authors:  A H Hou; D Swanson; A B Barqawi
Journal:  Adv Urol       Date:  2010-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.